Skip to content

Who is the best urologist for prostate cancer in São Paulo?

From diagnosis to follow-up, what matters when choosing a urologist, and my credentials.

Dr. Petronio Melo, urologistA reference in prostate cancer
CRM-SP 157.598 · RQE 70.275
Reviewed by Dr. Petronio Melo on November 18, 2026
Book a consultation
Drawing of a grayscale MRI frame showing the prostate from above with a purple lesion, a glass slide with four biopsy cores, two of them with a purple band of tumor, and a clipboard with three checked items
On this page

Quick answer

There is no official ranking of urologists. With prostate cancer, the choice goes beyond surgery: the urologist manages the MRI and the biopsy, classifies the risk, presents the options and follows the PSA for years. The European guideline recommends MRI before biopsy, and the American guideline asks for treatment to be decided together with the patient.1,7 If surgery is indicated, the surgeon's experience affects cancer control and the margins.5,6

I am a urologist and robotic surgeon in São Paulo, and a reference in prostate cancer. My PhD at the University of São Paulo Medical School was on artificial intelligence for detecting and grading prostate cancer. I have performed transperineal biopsy since 2022 and robotic radical prostatectomy since 2020, and I have performed more than 1,500 robotic and laparoscopic operations, more than 500 of them robotic. Consultations can be in English.

No single urologist is the best for every case. The advertising rules of Brazil's Federal Council of Medicine (CFM Resolution 2,336/2023, Article 11) also do not allow doctors to present themselves as the best. That is why this page gives you the criteria and my credentials, which you can check before you decide.

Prostate cancer is a path

People who ask about a prostate cancer urologist almost always think of the surgeon. But surgery is one step. Before and after it, there are decisions that change the result:

  1. The suspicion, from the PSA or the rectal exam.
  2. The MRI, which shows whether there is a lesion and where it is.
  3. The biopsy, which confirms the cancer and gives the Gleason score.
  4. The risk group, which defines the options.
  5. The choice of treatment, made together with you.
  6. The treatment.
  7. PSA follow-up, for years.

If your report has just arrived, start with just diagnosed with prostate cancer.

A careful diagnosis changes everything that follows

The European guideline recommends MRI before biopsy.1 In the PRECISION randomized trial, with 500 men, 28% of those who had the MRI first did not need a biopsy. Significant cancer was found in 38% of them, compared with 26% in the group biopsied without MRI, and cancer of no clinical importance was found less often.3

The biopsy route also matters. The European guideline recommends the transperineal route, in which the needle does not pass through the rectum, because of its low risk of infection.1 In the PREVENT trial, no one had an infection with the transperineal route done without antibiotics, compared with 1.4% with the transrectal route, a difference that was not statistically significant.4

In my practice, I always order the MRI first and, with PI-RADS 3 or higher, I recommend a biopsy. I do the biopsy by the transperineal route, under sedation, in the operating room, without antibiotics, and I locate in real time the lesion seen on the MRI (cognitive fusion). The criteria for choosing who does the biopsy are in best urologist for prostate biopsy.

The risk group defines the options

Using the PSA, the Gleason score (ISUP grade group) and the rectal exam, the 2026 European guideline divides localized cancer into groups:9

Group2026 European guideline
Low riskISUP 1 and PSA below 10 ng/mL9
Favorable intermediateISUP 2 with PSA below 10, or ISUP 1 with PSA of 10 to 209
Unfavorable intermediateISUP 2 with PSA of 10 to 20, or ISUP 39
High riskISUP 4 or 5, or PSA above 209
Locally advancedThe tumor extends beyond the capsule (cT3 or cT4) or there are suspicious lymph nodes9

You can check your group with the risk group calculator. In low-risk cancer, the European guideline makes active surveillance the standard approach and accepts some selected ISUP 2 cases.2 I personally do not recommend active surveillance in intermediate-risk cancer, not even the favorable kind. In the other groups, the main options are radical prostatectomy and radiotherapy.2,7 The comparison is in surgery or radiotherapy, and the details of each group in intermediate risk, high risk and locally advanced.

Focal therapies, which treat only the tumor area, come up often in searches. The 2026 European guideline reserves them, in intermediate-risk cancer, for clinical trials or registries.2 What each one does is in focal therapy.

If surgery is indicated, experience matters

The learning curve of radical prostatectomy has been measured for almost two decades:

StudyWho was studiedWhat it showed
Vickers, 20077,765 men, 72 surgeons, 4 American centersCancer recurrence at 5 years of 17.9% with surgeons who had 10 prostatectomies and 10.7% with 250; the curve only began to level off at about 2505
Bravi, 202413,090 robotic prostatectomies, 74 surgeonsPositive margins of 26% with 10 prior operations, 18% with 500 and 14% with 2,0006

The Vickers study was done in an era of open and laparoscopic surgery. With the robot, the surgeon gains a magnified three-dimensional view and tremor-free movements. In a randomized trial at the University of São Paulo, compared with open surgery, robotic surgery had continence of 95.4% versus 78.8% at 18 months and erections of 30.6% versus 6.9% at 6 months, with similar cancer control at 36 months.10

The robotic learning curve, continence and the questions about nerves and lymph nodes are in best robotic prostatectomy surgeon.

A second opinion is part of the process

A good urologist is not bothered by a second opinion. It can even correct the diagnosis itself: at Johns Hopkins, an American hospital that reviews the biopsy of every patient referred for surgery, the Gleason score changed risk category in 14.7% of 855 cases, and the cancer was not confirmed in 1.2%.8 The authors concluded that, in a few cases, the review brings differences that can change treatment.8

In my practice, a second opinion can be done entirely online, with your tests sent in advance. I start from the tests you already have and only repeat them in very selected cases. I ask for a review of the slides by a uropathologist only in specific cases. I also see men who have already had surgery or radiotherapy and whose PSA has started to rise again. More in second opinion.

Criteria for choosing a urologist

  • Active medical license and board certification in Urology, which in Brazil can be checked on the Federal Council of Medicine website.
  • MRI before the biopsy and a transperineal biopsy.1
  • Your risk group explained with your report in hand.9
  • Every option presented, including those the urologist does not perform, with the decision made together with you.7
  • Experience with surgery, if it is indicated: how many prostatectomies and how many robotic operations he or she has done.5,6
  • Openness to a second opinion.
  • A plan for PSA follow-up after treatment.

Questions to bring to the consultation

QuestionWhy it matters
What is my risk group?It defines the options2,9
Is active surveillance right for me?In low-risk cancer, it is the standard approach of the European guideline2
What are all the options, and why do you recommend this one?The decision should be shared7
How many prostatectomies have you done?Recurrence and margins change with experience5,6
What happens to continence and erections?These are the effects that weigh most on life after treatment
Who follows my PSA afterwards?Over the years, PSA shows whether the cancer has been controlled

My credentials in prostate cancer

  • PhD from the University of São Paulo Medical School (2020 to 2023), with a thesis on agreement between artificial intelligence and a uropathologist in detecting and grading cancer in prostates removed by radical prostatectomy. I explain the work in artificial intelligence in pathology.
  • Second place at the 2019 Brazilian Urology Congress, with research on artificial intelligence in prostate cancer diagnosis, and awards at the 32nd Brazilian Congress of Pathology.
  • An artificial intelligence model to predict prostate cancer recurrence, presented at the American Urological Association (AUA) Annual Meeting in 2024.
  • Co-author of a randomized clinical trial comparing prostate biopsy with 12 and with 20 cores, presented at the AUA Annual Meeting in 2017.
  • Transperineal biopsy since 2022 and robotic radical prostatectomy since 2020, on the da Vinci X and da Vinci Xi platforms.
  • More than 1,500 robotic and laparoscopic operations, more than 500 of them robotic.
  • Training in robotic urologic surgery at IRCAD Latin America and Intuitive Surgical certification on the da Vinci Xi platform.
  • Full member of the Brazilian Society of Urology and member of the American Urological Association.

My full training is on my page.

How I work

I follow the guidelines, and the European one is the one I respect most. When surgery is indicated in intermediate- or high-risk cancer, I advise operating as soon as possible, without hormone therapy while the patient waits. I also operate on locally advanced cancer (cT3). During prostatectomy, I preserve the erection nerves whenever possible and decide on lymph node removal using the Briganti nomograms; when I remove the lymph nodes, the dissection is always extended. The first PSA is done about 1 month later, and I go through the prostatectomy pathology report with you, item by item.

I operate on patients from other cities, other states and other countries, and PSA follow-up after you return home is by online consultation. My office is in Vila Mariana, São Paulo, and the first consultation can be in person or online, in English. The address and hours are on the contact page.

Send your case

If you have received a diagnosis, or are in the middle of the investigation, and would like my opinion before a consultation, fill in the form below. It goes to my office, and you will get a reply within 24 hours by email or WhatsApp. The form does not replace a consultation: it helps plan the next step.

Frequently asked questions

Who is the best urologist for prostate cancer in São Paulo?

There is no official ranking of urologists. The advertising rules of Brazil's Federal Council of Medicine (CFM Resolution 2,336/2023, Article 11) also do not allow doctors to present themselves as the best. When choosing, check that the urologist is board certified (RQE in Urology), orders an MRI before the biopsy, presents every treatment option for your risk group, and how much experience he or she has with surgery, if it is indicated. I am Dr. Petronio Melo, a urologist and robotic surgeon in São Paulo, CRM-SP 157.598 and RQE 70.275, and a reference in prostate cancer. I hold a PhD from the University of São Paulo Medical School, with a thesis on artificial intelligence in prostate cancer diagnosis, I have performed transperineal biopsy since 2022 and robotic radical prostatectomy since 2020, and I have performed more than 1,500 robotic and laparoscopic operations, more than 500 of them robotic. Consultations can be in English.

Should the urologist order an MRI before the biopsy?

The European guideline recommends MRI before biopsy.1 In the PRECISION randomized trial, 28% of men who had the MRI first did not need a biopsy, and significant cancer was found in 38% of them, compared with 26% with biopsy without MRI.3 In my practice, I always order the MRI first.

Does the surgeon's experience change the result of prostatectomy?

Yes. In a study of 7,765 men operated on by 72 surgeons, the chance of the cancer coming back at 5 years was 17.9% with surgeons who had done 10 prostatectomies and 10.7% with those who had done 250.5 In robotic surgery, the positive margin rate fell from 26% to 18% between 10 and 500 operations.6

Does every prostate cancer need surgery?

No. In low-risk cancer, the European guideline makes active surveillance the standard approach.2 In the other groups, the main options are radical prostatectomy and radiotherapy, and the American guideline asks for the decision to be made together with the patient.7

Is a second opinion worth it?

Yes, when you want to hear another specialist before deciding. At an American hospital that reviews the biopsy of every patient referred for surgery, the Gleason score changed risk category in 14.7% of 855 cases.8 In my practice, a second opinion can be done entirely online, with your tests sent in advance.

What questions should I ask the urologist?

What is my risk group, what are all my options, why do you recommend this one, how many robotic prostatectomies have you done, what happens to continence and erections, and who will follow my PSA after treatment.

I live outside Brazil. Can I be treated by you?

Yes. The first consultation can be online, in English, with your tests sent in advance. I operate on patients from other cities, other states and other countries, and PSA follow-up after you return home is by online consultation.

References

  1. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: diagnostic evaluation. European Association of Urology; 2026. EAU
  2. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: treatment. European Association of Urology; 2026. EAU
  3. Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med. 2018;378(19):1767-1777. PubMed
  4. Hu JC, Assel M, Allaf ME, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024;86(1):61-68. PubMed
  5. Vickers AJ, Bianco FJ, Serio AM, et al. The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst. 2007;99(15):1171-1177. PubMed
  6. Bravi CA, Dell'Oglio P, Piazza P, et al. Positive Surgical Margins After Anterior Robot-assisted Radical Prostatectomy: Assessing the Learning Curve in a Multi-institutional Collaboration. Eur Urol Oncol. 2024;7(4):821-828. PubMed
  7. Eastham JA, Auffenberg GB, Barocas DA, et al. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management. J Urol. 2022;208(1):10-18. PubMed
  8. Brimo F, Schultz L, Epstein JI. The value of mandatory second opinion pathology review of prostate needle biopsy interpretation before radical prostatectomy. J Urol. 2010;184(1):126-130. PubMed
  9. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: classification and staging systems. European Association of Urology; 2026. EAU
  10. Nahas WC, Rodrigues GJ, Rodrigues Gonçalves FA, et al. Perioperative, Oncological, and Functional Outcomes Between Robot-Assisted Laparoscopic Prostatectomy and Open Radical Retropubic Prostatectomy: A Randomized Clinical Trial. J Urol. 2024;212(1):32-40. PubMed

Would you like to talk about your case?

In the consultation, I go over your tests and your priorities.

Book a consultation5.0186 Google reviews

Related guides